Derek P Bergsma
Overview
Explore the profile of Derek P Bergsma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Allen S, Dragovic A, Yin H, Bryant A, Paximadis P, Matuszak M, et al.
Pract Radiat Oncol
. 2023 Apr;
13(5):444-453.
PMID: 37100388
Purpose: National guidelines on limited-stage small cell lung cancer (LS-SCLC) treatment give preference to a hyperfractionated regimen of 45 Gy in 30 fractions delivered twice daily; however, use of this...
2.
Bergsma D, Moravan M, Suri J, Cummings M, Usuki K, Singh D, et al.
J Thorac Dis
. 2022 Jul;
14(6):1869-1879.
PMID: 35813734
Background: We characterized long-term organ-specific patterns of recurrence, time to progression (TTP) and overall survival (OS) in patients with non-small cell lung cancer (NSCLC) with brain-only metastases treated with single-fraction...
3.
Bryant A, Yin H, Schipper M, Paximadis P, Boike T, Bergsma D, et al.
Am J Clin Oncol
. 2022 Mar;
45(4):142-145.
PMID: 35271524
Objectives: The addition of adjuvant durvalumab improves overall survival in locally advanced nonsmall-cell lung cancer (NSCLC) patients treated with definitive chemoradiation, but the real-world uptake of adjuvant durvalumab is unknown....
4.
Laucis A, Hochstedler K, Schipper M, Paximadis P, Boike T, Bergsma D, et al.
JCO Oncol Pract
. 2022 Feb;
18(6):e1034-e1044.
PMID: 35167337
Purpose: Historical racial disparities in lung cancer surgery rates resulted in lower survival in Black patients. Our objective was to examine racial differences in thoracic radiation treatments and toxicities in...
5.
Bergsma D, Salama J, Singh D, Chmura S, Milano M
Front Oncol
. 2017 Oct;
7:210.
PMID: 28975081
Non-small cell lung cancer (NSCLC) typically presents at an advanced stage, which is often felt to be incurable, and such patients are usually treated with a palliative approach. Accumulating retrospective...
6.
Cummings M, Youn P, Bergsma D, Usuki K, Walter K, Sharma M, et al.
Neurosurgery
. 2017 Sep;
83(3):437-444.
PMID: 28945885
Background: Optimal doses for single-fraction stereotactic radiosurgery (SRS) in the treatment of brain metastases are not well established. Our institution utilized conservative dosing compared to maximum-tolerated doses from the Radiation...
7.
Bergsma D, Schoeniger L, Bratton L, Katz A
Case Rep Oncol
. 2015 Nov;
8(3):416-22.
PMID: 26557080
Small-cell carcinoma (SCC), or high-grade neuroendocrine carcinoma of the stomach, is a rare subtype of extra-pulmonary SCC which is almost invariably lethal. Gastric SCC often presents with local symptoms indistinguishable...
8.
Bergsma D, Salama J, Singh D, Chmura S, Milano M
Expert Rev Anticancer Ther
. 2015 Nov;
15(12):1459-71.
PMID: 26536370
Non-small cell lung cancer (NSCLC) patients with metastases limited in site and number, termed oligometastases, may represent a unique subpopulation of advanced NSCLC with improved prognosis. The optimal management of...
9.
Guancial E, Roussel B, Bergsma D, Bylund K, Sahasrabudhe D, Messing E, et al.
Clin Interv Aging
. 2015 Jun;
10:939-49.
PMID: 26089655
Bladder cancer (BC) is an age-associated malignancy with increased prevalence in the elderly population. Elderly patients are a vulnerable population at increased risk for treatment-related toxicity secondary to medical comorbidities...
10.
McCurdy M, Bergsma D, Hyun E, Kim T, Choi E, Castillo R, et al.
J Radiat Oncol
. 2013 Jul;
2(2):203-208.
PMID: 23828730
Objective: We examined the relative response to radiation of the upper lung lobes (UL) versus lower lung lobes (LL) of normal lung tissue using normalized [F]-fluorodeoxyglucose (FDG) uptake per radiation...